Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Express Scripts (ESRX)

Express Scripts (ESRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Express Scripts Simplifies Digital Health Technology Marketplace for Consumers and Payers

To make it simpler for consumers and payers to navigate the hundreds of thousands of currently available personal health technologies and interventions, Express Scripts, a Cigna company, will introduce...

ESRX : 92.33 (-3.62%)
Medvantx Expanding Pharmacy Team to Include Chief Pharmacy Officer - Focusing on Innovation and Quality Systems to Support Company's Novel E-Commerce Enabled Direct to Patient Pharmacy Channel

Medvantx, Inc., the leading provider of ecommerce enabled pharmacy solutions, is pleased to announce the addition of Slater Nash, as Chief Pharmacy Officer. Slater joins Medvantx from Express Scripts,...

ESRX : 92.33 (-3.62%)
Titan Pharmaceuticals Further Expands Patient Access To Probuphine® Via Product Purchase And Supply Agreement With Express Scripts' Specialty Pharmacy, Accredo®

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced that it has executed a product purchase and supply agreement with Accredo specialty pharmacy, a subsidiary of Express Scripts, further expanding...

ESRX : 92.33 (-3.62%)
TTNP : 1.42 (-2.07%)
Express Scripts Ranked as a Top 50 Inclusive Company by DiversityInc

Express Scripts, through its commitment to diversity and inclusion, has earned recognition among the Top 50 inclusive companies in the nation by DiversityInc. This recognition includes being named the...

ESRX : 92.33 (-3.62%)
Express Scripts Canada 2019 Prescription Drug Trend Report - nonadherence an alarming trend

Depending on the conditions for which they are being treated, as many as 70 percent of Canadian patients are not taking their medications as directed by their physicians. These statistics are among the...

ESRX : 92.33 (-3.62%)
Express Scripts and Appriss Health Create New Military Health System Prescription Drug Monitoring Program

Express Scripts, one of the nation's leading pharmacy benefit managers, and Appriss Health, provider of the most comprehensive prescription drug monitoring platform for addressing substance use disorder...

ESRX : 92.33 (-3.62%)
Accredo, a Full-Service Specialty Pharmacy, Expands Best-in-Class Services with New Pharmacy in Hawaii

Express Scripts today announced that its specialty pharmacy, Accredo, will open a new location in Honolulu to provide high-touch pharmacy care to people living with chronic, complex health conditions,...

ESRX : 92.33 (-3.62%)
Express Scripts Down 3.4% Since SmarTrend Downtrend Call (ESRX)

SmarTrend identified a Downtrend for Express Scripts (NASDAQ:ESRX) on December 10th, 2018 at $95.57. In approximately 4 months, Express Scripts has returned 3.39% as of today's recent price of $92.33....

ESRX : 92.33 (-3.62%)
MAVENCLAD® (Cladribine) Tablets Now Covered by Express Scripts

EMD Serono, Inc. today announced that Express Scripts is covering on its formulary the oral multiple sclerosis (MS) therapy, MAVENCLAD® (cladribine) tablets, which was approved by the U.S. Food and Drug...

ESRX : 92.33 (-3.62%)
Cigna and Express Scripts Further Enhance Customer Service Offerings Through New Collaboration with Amazon Alexa

Cigna and Express Scripts have collaborated with Amazon Alexa to launch two voice skills to make health care more engaging, personalized and convenient for customers. The Cigna and Express...

ESRX : 92.33 (-3.62%)
CI : 161.15 (+0.88%)
Cigna and Express Scripts Introduce Patient Assurance Program to Cap Out Of Pocket Costs at $25 per 30-Day Insulin Prescription

--Improves affordability and predictability of insulin costs for people with diabetes and their participating plans

ESRX : 92.33 (-3.62%)
CI : 161.15 (+0.88%)
Michael Roszak joins Express Scripts Canada

Express Scripts Canada (ESC) is pleased to announce that Michael (Mike) Roszak has accepted the position of Chief Operating Officer. Michael will oversee operations, customer services, marketing, sales...

ESRX : 92.33 (-3.62%)
Express Scripts Data Shows Value-Based Programs Deliver Better Health, Affordability for Costly Conditions

According to new data released today, the Express Scripts SafeGuardRx® offering - the company's first-to-market value-based programs for employers and health plans - improved patient engagement and increased...

ESRX : 92.33 (-3.62%)
ValoremRx Collaborates with Kroger Specialty Pharmacy to Improve Access and Patient Care

ValoremRx Specialty Solutions, the group purchasing organization (GPO) formed by a joint venture between Express Scripts and Walgreens, today announced its new collaboration with Kroger Specialty Pharmacy....

ESRX : 92.33 (-3.62%)
Express Scripts Canada Renews Contract with iA Financial Group

Express Scripts Canada secures enduring relationship with iA Financial Group to provide Claim Management Services

ESRX : 92.33 (-3.62%)
HIMSS '19: Data-Driven Tools from Cigna and Express Scripts Boost Access to Real-Time Prescription Savings Opportunities

--ScriptVision(TM) (beta) physician mobile application is a new addition to the Express Scripts suite of digital provider solutions to enable physicians and personalize care for patients.

ESRX : 92.33 (-3.62%)
CI : 161.15 (+0.88%)
RFPIO to Provide Enterprise-Wide Response Management Solution to Express Scripts

RFPIO, the leader in cloud-based RFP response management software, today announced that Express Scripts, part of Cigna Corporation, a health services leader that delivers personalized solutions to improve...

ESRX : 92.33 (-3.62%)
Express Scripts Saved Plans $45 Billion on Prescription Drugs in 2018

Express Scripts clinical innovations saved its clients $45 billion in 2018 and delivered a 25-year record low drug trend of just 0.4 percent across employer-sponsored plans, according to data released...

ESRX : 92.33 (-3.62%)
Cigna Delivers Strong 2018 Results as it Completes Express Scripts Transaction; Company Positioned for Significant Growth

--Shareholders' net income for 2018 was $2.6 billion, or $10.54 per share

ESRX : 92.33 (-3.62%)
CI : 161.15 (+0.88%)
Photo of Cigna Building Blessings in a Backpack in Nashville Available on Business Wire's Website and the Associated Press Photo Network

A photo is available on Business Wire's website and the Associated Press photo network of Cigna and Express Scripts employees in Nashville celebrating the combination of their companies by...

ESRX : 92.33 (-3.62%)
CI : 161.15 (+0.88%)

Van Meerten Stock Picks

Cohen & Steers REIT ETF
My Pick of the Day is the Cohen & Steers REIT ETF (ICF).
ICF -1.45
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar